Beatrice (psychedelic)

Beatrice (psychedelic)
Names
	IUPAC name 1-(2,5-dimethoxy-4-methylphenyl)-N-methylpropan-2-amine
	Other names 4-Methyl-2,5-dimethoxy-methamphetamine; 2-(4-Methyl-2,5-dimethoxyphenyl)ethan-alpha,N-methylamine
Identifiers
CAS Number	92206-37-6
ChEMBL	ChEMBL19044
ChemSpider	184247
Jmol interactive 3D	Image
PubChem	212480
	InChI InChI=1S/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3 Key: IWYGVDBZCSCJGT-UHFFFAOYSA-N ; InChI=1/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3 Key: IWYGVDBZCSCJGT-UHFFFAOYAZ ;
	SMILES O(c1cc(c(OC)cc1CC(NC)C)C)C ;
Properties
Chemical formula	C13H21NO2
Molar mass	223.3126 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

Beatrice, MDO-D, MDOM, or 4-methyl-2,5-dimethoxy methamphetamine, is a lesser-known psychedelic drug. It is an analog of Methamphetamine and a homolog of DOM. Beatrice was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 30 mg, and the duration listed as 6–10 hours. Beatrice produces a vague feeling of openness and receptiveness, and causes a stimulative effect. It also causes diarrhea. Very little data exists about the pharmacological properties, metabolism, and toxicity of Beatrice.

References[edit]

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.